Literature DB >> 33647908

Long Noncoding RNA PRNCR1 Reduces Renal Epithelial Cell Apoptosis in Cisplatin-Induced AKI by Regulating miR-182-5p/EZH1.

Jing Li1, Xing Fan1, Qian Wang1, Youlan Gong1, Li Guo2.   

Abstract

BACKGROUND/AIMS: This study was designed to examine the role of long noncoding RNA PRNCR1 in cisplatin-induced acute kidney injury (AKI) in vitro and in vivo.
METHODS: The expression levels of PRNCR1 and miR-182-5p in cisplatin-induced AKI mice were examined. HK-2 cells were treated with cisplatin to induce cell damage. Then, the effects of PRNCR1 and miR-182-5p on cisplatin-stimulated HK-2 cell viability and apoptosis were detected by the CCK-8 and annexin V-FITC/PI method. Target genes of PRNCR1 and miR-182-5p were analyzed by bioinformatics analysis and luciferase.
RESULTS: The expression level of PRNCR1 was significantly reduced in cisplatin-induced AKI mice. In addition, overexpression of PRNCR1 attenuated the damage of cisplatin to HK-2. The expression level of miR-182-5p was significantly raised in cisplatin-induced AKI mice. MiR-182-5p was negatively regulated by PRNCR1 and leaded to an upregulation of EZH1 expression. Overexpression of PRNCR1 attenuated cisplatin-induced apoptosis by downregulating the miR-182-5p/EZH1 axis.
CONCLUSION: LncPRNCR1 reduced the apoptosis of renal epithelial cells induced by cisplatin by modulating miR-182-5p/EZH1.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Apoptosis; EZH1; LncPRNCR1; Proliferation; miR-182-5p

Year:  2021        PMID: 33647908     DOI: 10.1159/000510157

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  6 in total

Review 1.  Cisplatin nephrotoxicity: new insights and therapeutic implications.

Authors:  Chengyuan Tang; Man J Livingston; Robert Safirstein; Zheng Dong
Journal:  Nat Rev Nephrol       Date:  2022-10-13       Impact factor: 42.439

2.  LncRNA136131 suppresses apoptosis of renal tubular epithelial cells in acute kidney injury by targeting the miR-378a-3p/Rab10 axis.

Authors:  Zhifen Wu; Jian Pan; Jurong Yang; Dongshan Zhang
Journal:  Aging (Albany NY)       Date:  2022-04-28       Impact factor: 5.682

Review 3.  Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review.

Authors:  Nadine de Godoy Torso; João Kleber Novais Pereira; Marília Berlofa Visacri; Pedro Eduardo Nascimento Silva Vasconcelos; Pía Loren; Kathleen Saavedra; Nicolás Saavedra; Luis A Salazar; Patricia Moriel
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

Review 4.  An Update of Long-Noncoding RNAs in Acute Kidney Injury.

Authors:  Lina Yang; Bo Wang; Liang Ma; Ping Fu
Journal:  Front Physiol       Date:  2022-03-08       Impact factor: 4.566

Review 5.  MicroRNAs Involved in Intrinsic Apoptotic Pathway during Cisplatin-Induced Nephrotoxicity: Potential Use of Natural Products against DDP-Induced Apoptosis.

Authors:  Pía Loren; Yuliannis Lugones; Nicolás Saavedra; Kathleen Saavedra; Isis Páez; Nelia Rodriguez; Patricia Moriel; Luis A Salazar
Journal:  Biomolecules       Date:  2022-08-31

Review 6.  Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update.

Authors:  Pía Loren; Nicolás Saavedra; Kathleen Saavedra; Tomás Zambrano; Patricia Moriel; Luis A Salazar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.